Skip to main content

Stefania Landolfi

Sóc especialista en anatomia patològica i treballo a l'Hospital Vall d'Hebron des de 2005 amb dedicació gairebé exclusiva a la patologia digestiva, tant malalties neoplàstiques com no tumorals.

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca
Doctor
Pathological anatomy
Cross-departmental services
Vaig realitzar la meva residència en Anatomia Patològica a Torí (Itàlia) i a l'Hospital Clínic de Barcelona. Treballo en el Servei d'Anatomia Patològica de l'Hospital Vall d'Hebron des del 2005, al principi vinculada al laboratori d'Oncologia Molecular, on el meu treball estava relacionat principalment a assajos clínics. Des del 2006 sóc facultativa especialista del Servei d'Anatomia Patològica de l'Hospital Vall d'Hebron. La meva activitat assistencial i de recerca se centra principalment en la patologia digestiva tumoral i funcional / inflamatòria, on sóc referent i en la patologia urològica. Sóc membre de la Societat Espanyola d'Anatomia Patològica (SEAP), de l'European Society of Pathology (ESP) i de l'European Neuroendocrine Tumor Society (ENETS). Des de 2012 sóc professora associada del Departament de Ciències Morfològica (Facultat de Medicina, UAB).

Projects

FUSOMAP: Development of microbiota-based diagnostic and prognostic models by mapping intratumoral Fusobacterium and associated gut microbiota in early-stage colorectal cancer

IP: FUSOMAP: Development of microbiota-based diagnostic and prognostic models by mapping intratumoral Fusobacterium and associated g
Collaborators: FUSOMAP: Development of microbiota-based diagnostic and prognostic models by mapping intratumoral Fusobacterium and associated g, FUSOMAP: Development of microbiota-based diagnostic and prognostic models by mapping intratumoral Fusobacterium and associated g, Stefania Landolfi
Funding agency: Instituto de Salud Carlos III
Funding: 208120
Reference: PI20/00889
Duration: 01/01/2021 - 31/12/2023

Identification and validation of sensitivity signatures and mechanisms of resistance and response to targeted therapies and immunotherapy in patients with advanced colorectal cancer

IP: Identification and validation of sensitivity signatures and mechanisms of resistance and response to targeted therapies and immu
Collaborators: Lorena Ramirez Corpas, Cristina Viaplana Donato, Identification and validation of sensitivity signatures and mechanisms of resistance and response to targeted therapies and immu, Identification and validation of sensitivity signatures and mechanisms of resistance and response to targeted therapies and immu, Identification and validation of sensitivity signatures and mechanisms of resistance and response to targeted therapies and immu, Stefania Landolfi
Funding agency: Instituto de Salud Carlos III
Funding: 242000
Reference: PI20/00968
Duration: 01/01/2021 - 31/12/2023

Identificación de un panel integrado de biomarcadores no invasivos predictivos del diagnóstico de colitis microscópica

IP: Danila Guagnozzi
Collaborators: Beatriz Lobo Alvarez, Ana Maria Gonzalez Castro, Lara Aguilera Castro, Marc Pigrau Pastor, Stefania Landolfi
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01443
Duration: 01/01/2018 - 30/06/2022

RHOA signaling in gastric cancer: friend or foe?

IP: Diego Arango Corro
Collaborators: Nivardo Rodríguez Conde, Manuel Armengol Carrasco, RHOA signaling in gastric cancer: friend or foe?, RHOA signaling in gastric cancer: friend or foe?, Stefania Landolfi , Elena Andretta
Funding agency: Asociación Española Contra el Cáncer
Funding: 1015000
Reference: 2015/AECC-GCE/ARANGO
Duration: 01/07/2015 - 30/06/2022

Related news

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

On World Cancer Research Day, we highlight the impact of VHIR projects in the field of oncology.

Related professionals

Gloria M. Gálvez Hernando

Gloria M. Gálvez Hernando

Administration and Management
Read more
Montserrat Munill Ferrer

Montserrat Munill Ferrer

New Technologies and Craniofacial Microsurgery
Read more
Marta Allué López

Marta Allué López

Read more
Vanesa Félix Brenes

Vanesa Félix Brenes

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.